Yasmin and Yaz: New Lawsuit on Deep Vein Thrombosis

Share Article

According to court documents, on July 11th, 2012, two Colorado women, Evelyn Heidi Cottle and Tara Goggin, filed a lawsuit in Illinois Southern District Court (case no. 3:2012cv11107) claiming severe injuries, including deep vein thrombosis (DVT), from taking Yasmin and Yaz. Yasmin, which was approved by the FDA in 2001, and its sister drug Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. Yaz and Yasmin are manufactured by Bayer Healthcare Pharmaceuticals. The case joins the Yasmin/Yaz Multidistrict Litigation (MDL 2100). Now, AttorneyOne.com, a recognized authority on law, can provide helpful, proven advice and simple solutions including how to get in contact with legal counsel so anyone can easily and inexpensively deal with cases of Yasmin severe adverse events. [http://www.attorneyone.com/yasmin-lawsuits/

Yasmin and Yaz: severe adverse events threat

Yasmin and Yaz: severe adverse events threat

claiming severe injuries, including deep vein thrombosis (DVT), from taking Yasmin and Yaz

The media spotlight is often a double-edged sword. No one knows this better than Evelyn Heidi Cottle and Tara Goggin. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.

According to court documents, on July 11th, 2012, two Colorado women, Evelyn Heidi Cottle and Tara Goggin, filed a lawsuit in Illinois Southern District Court (case no. 3:2012cv11107) claiming severe injuries, including deep vein thrombosis (DVT), from taking Yasmin and Yaz. Yasmin, which was approved by the FDA in 2001, and its sister drug Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. Yaz and Yasmin are manufactured by Bayer Healthcare Pharmaceuticals.

In the lawsuit Cottle claims she started using Yaz in 2010 and stopped a few months later. As a result of Yaz, she alleges been diagnosed with DVT. Goggin claims she started using Yasmin in 2011, and stopped a few months later. She allegedly suffered DVT and a pulmonary embolism in December 2011. The case joins the Yasmin/Yaz Multidistrict Litigation (MDL 2100).

AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Yasmin/Yaz, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Yasmin/Yaz remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”

As BusinessWeek reported on July 31st, 2012, Bayer said settlements of U.S. lawsuits over claims that its Yasmin line of birth-control pills caused blood clots in women have increased to more than $402 million. In a stockholders’ newsletter Bayer said that it has resolved almost 1,900 cases, in which its Yasmin and Yaz contraceptives allegedly caused clots that can lead to heart attacks and strokes, for an average of approximately $212,000 a case.

AttorneyOne.com has further information on Yasmin lawsuits including how to get in contact with legal counsel.

Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/9/prweb9934327.htm.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Sean Burke
Visit website